LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why

Core Viewpoint - Growth investors are focused on stocks with above-average financial growth, but identifying such stocks can be challenging due to inherent risks and volatility [1] Group 1: Company Overview - LeMaitre Vascular (LMAT) is highlighted as a recommended stock with a favorable Growth Score and a top Zacks Rank [2] - The company has a historical EPS growth rate of 13.7%, with projected EPS growth of 17.2% this year, surpassing the industry average of 11.4% [5] Group 2: Financial Metrics - LeMaitre's year-over-year cash flow growth is 35.1%, significantly higher than the industry average of 1.2% [6] - The company's annualized cash flow growth rate over the past 3-5 years is 18.1%, compared to the industry average of 8% [7] Group 3: Earnings Estimates - There has been a positive trend in earnings estimate revisions for LeMaitre, with the Zacks Consensus Estimate for the current year increasing by 5.6% over the past month [8] Group 4: Investment Potential - LeMaitre has earned a Growth Score of B and a Zacks Rank 2, indicating it is a potential outperformer and a solid choice for growth investors [10]